Patients with pancreas or biliary tract cancer who have not thrombosis
Conditions
Interventions
None listed
Sponsors
Kanagawa Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Part I; 1)clinically or pathologically diagnosed as pancreas or biliary tract cancer, 2)clinically diagnosed as resectable before the operation, 3)provided written informed consent, 4)without obstructive jaundice nor acute pancreatitis Part II; 1)clinically or pathologically diagnosed as pancreas or biliary tract cancer, 2)clinically diagnosed as unresectable, 3)provided written informed consent, 4)without obstructive jaundice nor acute pancreatitis
Exclusion criteria
Exclusion criteria: Part I; 1)have the medical history of thromboembolism whithin 5 years or have thrombosis at the time of inclusion, 2)inappropriate to this this study judged by the investigator Part II; 1)have the medical history of thromboembolism whithin 5 years or have thrombosis at the time of inclusion, 2)allergy to the contrast enhancing media, 3)intake regularly anti-coagulant agent, 4)with obstrucive janudice or acute pancreatitis, 5)inappropriate to this this study judged by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The concentration of tissue factor in resected specimen(Part I). The relationship between the microparticle level of tissue factor in the serum and the incidence of thromboembolism(Part II) | — |
Countries
Japan
Contacts
Public ContactSatoshi Kobayashi
Kanagawa Cancer Center Division of Hepatobiliary and Pancreas Oncology
Outcome results
None listed